XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Share Based Compensation Options Awarded

 Schedule of Share Based Compensation Options Awarded

            Number of options 
2023
    Weighted average of exercise price     Number of options 
Outstanding as of beginning of year   $ 0.4      13,943,842 
Granted   $ 0.58      2,467,000 
Cancelled   $ 0.32      (866,667)
Outstanding as of end of year   $ 0.42      15,544,175 
Schedule of Stock-Based Compensation Expenses

Schedule of Stock-Based Compensation Expenses 

   2023   2022 
   Year ended December 31 
   2023   2022 
   US Dollars (In thousands) 
Research and development expenses   158    111 
Marketing expenses   659    472 
General and administrative expenses   865    747 
           
Total stock-based compensation   1,682    1,330 
Schedule of Stock Options, Valuation Assumptions

 

   For the years ended 
   December 31   December 31 
   2023   2022 
         
Dividend yields (see (I) below)   0.0%   0.0%
Share price (in U.S. dollar) (see (II) below)   0.53,0.64    0.53,0.26 
Expected volatility (see (III) below)   116%-84%    82.77%-142.57% 
Risk-free interest rates (see (IV) below)   3.61%-4.39%    0.18%-4% 
Expected life (in years) (see (V) below)   1.5-14.79    1.5-14.79 

 

  I. The Group used 0% as its expected dividend yield, based on historic policies and future plans.
     
  II. The Company’s common stock is quoted on the OTCQB. However, the Company considers its share price as it is traded on OTCQB to not be an appropriate representation of fair value, since it is not traded on an active market. The Company determined that the market is inactive due to low level of activity of the Company’s common stock, stale or non-current price quotes and price quotes that vary substantially either over time or among market makers. Consequently, the price of the Company’s common stock has been determined based on private placement equity offerings conducted in April 2021, July 2022 and June 2023 consisting of units comprised of shares of common stock and warrants, at a per unit purchase price of $0.64, $0.88 and $1.00, respectively. In order to evaluate the price per share, the warrant value has been deducted from the total unit price.
     
  III. As the Company is at its early stage of operation, there is not sufficient historical volatility for the expected term of the stock options. Therefore, the Group uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly traded companies which were selected based upon industry similarities.
     
  IV. The Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect as of the date of grant.
     
  V. The expected life of the granted options was determined based on the estimated behavior of the grantees; since most of the grantees are executives, the Company assumed that the large majority of the options will be exercised prior to their expiration.